Insilico Medicine expands synthetic lethality
New York, Might 5, 2022/PRNewswire/-- Insilico Drugs (“Insilico”), a clinical-stage end-to-end synthetic intelligence (AI)-driven drug discovery firm, right now introduced ...
Tag: Lethality
Insilico Medicine Announces Advancement of Its Preclinical Candidate for USP1 Synthetic Lethality Target to IND-enabling Studies for Various Oncological Disorders
Insilico Drugs Nominates Its USP1 Small Molecule Inhibitor as a Preclinical Candidate for Tumors with Homologous Recombination Deficiency NEW YORK, ...
POPULAR NEWS
EDITOR'S PICK
